AMZN
Amazon.com, Inc.
AMZN has the edge over GCO overall, supported by stronger valuation and lower modeled downside.
GCO
Genesco Inc.
GCO's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
GCO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
GCO's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over GCO in the historical PE scenario, which offers more potential upside but is not a forecast.
GCO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6x | $23.89 | -33% |
| Fair | 7.3x | $28.93 | -19% |
| Current | 9x | $35.78 | — |
| Forward | 12x | $35.78 | — |
| Expensive | 20x | $78.41 | +119% |
Historical ranges are pointers, not guarantees.
GCO's PE is in its expensive range at 9.0x. On analysts' estimates for next year's earnings, today's price would be 12x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over GCO on the outlook, with more favorable revenue expectations.
GCO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect GCO's earnings to grow and its profitability to improve, with its revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over GCO on earnings, with more consistent year-over-year improvement.
GCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.09 | -22% |
| Q3 2026 | $3.96 | +$6.37 |
| Q2 2026 | $1.85 | +$3.38 |
| Q1 2026 | $1.25 | +$2.99 |
| Q4 2025 | -$0.15 | +$2.46 |
| Q3 2025 | -$2.41 | -$2.16 |
| Q2 2025 | -$1.53 | +$0.60 |
| Q1 2025 | -$1.74 | -$0.24 |
| Q4 2024 | -$2.61 | -$1.87 |
GCO has returned to profit: it earned $3.96 per share over the past year, after losing money the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over GCO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over GCO on profitability, with a higher operating margin.
GCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $529.9M | -3% |
| Q2 2026 | $487M | +2.8% |
| Q1 2026 | $799.9M | +7.2% |
| Q4 2025 | $616.2M | +3.3% |
| Q3 2025 | $546M | +4% |
| Q2 2025 | $474M | +3.6% |
| Q1 2025 | $745.9M | +0.9% |
| Q4 2024 | $596.3M | +2.9% |
GCO's revenue grew through 2021 and has held roughly level since: $530M last quarter, down 3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.7% | +3.3 points |
| Q2 2026 | -3.2% | +2.8 points |
| Q1 2026 | 6.4% | +0.2 points |
| Q4 2025 | 1.4% | -0.3 points |
| Q3 2025 | -2.6% | -0.7 points |
| Q2 2025 | -5.9% | +1.1 points |
| Q1 2025 | 6.2% | +1.1 points |
| Q4 2024 | 1.7% | -0.2 points |
GCO's operating margin was 0.7% last quarter, up 3.3 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
GCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60M | -16% |
| Q2 2026 | -$118.2M | +$1.7M |
| Q1 2026 | $163.5M | +58% |
| Q4 2025 | -$31.5M | +$4.7M |
| Q3 2025 | $71.7M | +262% |
| Q2 2025 | -$119.9M | -$79.8M |
| Q1 2025 | $103.3M | -4.2% |
| Q4 2024 | -$36.2M | -$23.4M |
GCO has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over GCO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
GCO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.7% | +489K shares |
| 1 year | +6.1% | +623K shares |
| 3 years | -3.8% | -427K shares |
| 5 years | -25% | -3.7M shares |
| Available history | -25% | -3.6M shares |
GCO has 11M diluted shares, up 6.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $12.6M |
| Q1 2025 | — |
| Q4 2024 | $440,000 |
GCO hasn't bought back shares in the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
GCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.4x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | -1.4x | Net Cash |
| Q4 2025 | 1.0x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | 1.1x | Healthy |
GCO has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
GCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.6 | Neutral |
| Stochastic | 52.5 | Neutral |
GCO's weekly RSI is 52 (neutral) and its Stochastic is 53 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
GCO PE vs Consumer Cyclical Sector
| Metric | GCO | Sector median | Relative |
|---|---|---|---|
| PE | 9x | 18x | 50% below |
| PE % | 68 | 47 | 21 pts above |
GCO has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over GCO on trend strength, trading above more of its moving averages.
GCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.2 | 1.1% below |
| 20 week MA | $35.6 | 0.4% above |
| 50 week MA | $32.9 | 8.9% above |
| 100 week MA | $30.9 | 16% above |
| 200 week MA | $30.6 | 17% above |
GCO's trend is up, with a small recent dip: it's below only its 8-week average, and 17% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
GCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.2 | $27.9 | -42% |
| 2021 | $27.9 | $59.8 | +114% |
| 2022 | $59.8 | $44.2 | -26% |
| 2023 | $44.2 | $35.2 | -20% |
| 2024 | $35.2 | $42.1 | +20% |
| 2025 | $42.1 | $25.6 | -39% |
| 2026 YTD | $25.6 | $35.8 | +40% |
GCO has the edge over AMZN on returns for 2026, with the stronger performance.